An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

ClinicalTrials.gov ID: NCT06129240

Public ClinicalTrials.gov record NCT06129240. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jun 26, 2026, 8:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in Pulmonary Hypertension

Study identification

NCT ID: NCT06129240
Recruitment status: Recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: Liquidia Technologies, Inc.; Industry
Enrollment: 80 participants

Conditions and interventions

Conditions

Interventions

LIQ861 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 27, 2023
Primary completion: Jul 30, 2027
Completion: Feb 7, 2028
Last update posted: Jun 25, 2026

2023 – 2028

United States locations

U.S. sites: 23
U.S. states: 17
U.S. cities: 23

Facility	City	State	ZIP	Site status
Arizona Pulmonary Specialists	Phoenix	Arizona	85012	Recruiting
The Medical Research Group, Inc.	Fresno	California	93720	Recruiting
University of California San Diego	La Jolla	California	92093	Withdrawn
UCLA Westwood	Los Angeles	California	90095	Active, not recruiting
UC Davis	Sacremento	California	95817	Active, not recruiting
UCSF	San Francisco	California	94143	Active, not recruiting
National Jewish Health	Denver	Colorado	80206	Recruiting
Hartford Hospital	Hartford	Connecticut	06102	Withdrawn
Advent Health	Orlando	Florida	32803	Recruiting
Tampa General Hospital Center of Research Excellence	Tampa	Florida	33606	Recruiting
Vincent Medical Group	Indianapolis	Indiana	46260	Recruiting
Norton Pulmonary Specialists	Louisville	Kentucky	40241	Withdrawn
Tufts Medical Center	Boston	Massachusetts	02111	Withdrawn
University of Michigan	Ann Arbor	Michigan	48109	Active, not recruiting
University of Minnesota	Minneapolis	Minnesota	55455	Active, not recruiting
NYU Langone Medical Center	New York	New York	10016	Active, not recruiting
University of Rochester	Rochester	New York	14627	Active, not recruiting
University of North Carolina at Chapel Hill	Chapel Hill	North Carolina	27514	Withdrawn
University of Cincinnati Health	Cincinnati	Ohio	45219	Active, not recruiting
Summit Health	Bend	Oregon	97701	Recruiting
Medical University of South Carolina	Charleston	South Carolina	29425	Recruiting
Houston Methodist	Houston	Texas	77030	Active, not recruiting
University of Utah	Salt Lake City	Utah	84112	Active, not recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06129240, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 25, 2026 · Synced Jun 26, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06129240 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →